Helicobacter pylori infection, host genetics and gastric cancer

Anne-Marie Shanks, Emad M El-Omar

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

Helicobacter pylori infects half the world's population and is responsible for a considerable global health burden, including peptic ulcer disease and gastric cancer. The infection causes a chronic gastritis, the severity and distribution of which determine the clinical outcome. Bacterial, environmental and host genetic factors combine to define the degree of gastric damage. Most patients have a limited mild pan-gastritis with no significant clinical consequences. Antral-predominant gastritis is associated with high gastric acid output and an increased risk of duodenal ulcers. Corpus-predominant gastritis is associated with a reduction in gastric acid, multifocal gastric atrophy and an increased risk of gastric cancer. Host genetic factors are particularly important in defining the severity and extent of Helicobacter-induced gastritis. The most relevant and consistent genetic factors uncovered thus far are in the interleukin-1 and tumor necrosis factor-A gene clusters. These cytokines appear to play a key role in the pathophysiology of gastric cancer and their roles have been confirmed in animal models that mimic human gastric neoplasia. More genetic factors have also been uncovered and, with advancing technology, there is every prospect of defining a full genetic risk profile in the next decade. This will aid in targeting the testing and treatment of Helicobacter pylori, which offers a true opportunity to prevent and defeat this global killer.
Original languageEnglish
Pages (from-to)157-164
Number of pages8
JournalJournal of Digestive Diseases
Volume10
Issue number3
Early online date23 Jul 2009
DOIs
Publication statusPublished - Aug 2009

Fingerprint

Helicobacter Infections
Gastritis
Helicobacter pylori
Stomach Neoplasms
Stomach
Gastric Acid
Helicobacter
Duodenal Ulcer
Multigene Family
Peptic Ulcer
Interleukin-1
Atrophy
Animal Models
Tumor Necrosis Factor-alpha
Cytokines
Technology
Infection
Population
Neoplasms

Keywords

  • gastritis
  • helicobacter infections
  • helicobacter pylori
  • humans
  • interleukin-1
  • multigene family
  • peptic ulcer
  • polymorphism, single nucleotide
  • tumor necrosis factor-alpha
  • virulence factors

Cite this

Helicobacter pylori infection, host genetics and gastric cancer. / Shanks, Anne-Marie; El-Omar, Emad M.

In: Journal of Digestive Diseases, Vol. 10, No. 3, 08.2009, p. 157-164.

Research output: Contribution to journalArticle

Shanks, Anne-Marie ; El-Omar, Emad M. / Helicobacter pylori infection, host genetics and gastric cancer. In: Journal of Digestive Diseases. 2009 ; Vol. 10, No. 3. pp. 157-164.
@article{e2c0efddc74041a1a306f43109b197ee,
title = "Helicobacter pylori infection, host genetics and gastric cancer",
abstract = "Helicobacter pylori infects half the world's population and is responsible for a considerable global health burden, including peptic ulcer disease and gastric cancer. The infection causes a chronic gastritis, the severity and distribution of which determine the clinical outcome. Bacterial, environmental and host genetic factors combine to define the degree of gastric damage. Most patients have a limited mild pan-gastritis with no significant clinical consequences. Antral-predominant gastritis is associated with high gastric acid output and an increased risk of duodenal ulcers. Corpus-predominant gastritis is associated with a reduction in gastric acid, multifocal gastric atrophy and an increased risk of gastric cancer. Host genetic factors are particularly important in defining the severity and extent of Helicobacter-induced gastritis. The most relevant and consistent genetic factors uncovered thus far are in the interleukin-1 and tumor necrosis factor-A gene clusters. These cytokines appear to play a key role in the pathophysiology of gastric cancer and their roles have been confirmed in animal models that mimic human gastric neoplasia. More genetic factors have also been uncovered and, with advancing technology, there is every prospect of defining a full genetic risk profile in the next decade. This will aid in targeting the testing and treatment of Helicobacter pylori, which offers a true opportunity to prevent and defeat this global killer.",
keywords = "gastritis, helicobacter infections, helicobacter pylori, humans, interleukin-1, multigene family, peptic ulcer, polymorphism, single nucleotide, tumor necrosis factor-alpha, virulence factors",
author = "Anne-Marie Shanks and El-Omar, {Emad M}",
year = "2009",
month = "8",
doi = "10.1111/j.1751-2980.2009.00380.x",
language = "English",
volume = "10",
pages = "157--164",
journal = "Journal of Digestive Diseases",
issn = "1751-2972",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Helicobacter pylori infection, host genetics and gastric cancer

AU - Shanks, Anne-Marie

AU - El-Omar, Emad M

PY - 2009/8

Y1 - 2009/8

N2 - Helicobacter pylori infects half the world's population and is responsible for a considerable global health burden, including peptic ulcer disease and gastric cancer. The infection causes a chronic gastritis, the severity and distribution of which determine the clinical outcome. Bacterial, environmental and host genetic factors combine to define the degree of gastric damage. Most patients have a limited mild pan-gastritis with no significant clinical consequences. Antral-predominant gastritis is associated with high gastric acid output and an increased risk of duodenal ulcers. Corpus-predominant gastritis is associated with a reduction in gastric acid, multifocal gastric atrophy and an increased risk of gastric cancer. Host genetic factors are particularly important in defining the severity and extent of Helicobacter-induced gastritis. The most relevant and consistent genetic factors uncovered thus far are in the interleukin-1 and tumor necrosis factor-A gene clusters. These cytokines appear to play a key role in the pathophysiology of gastric cancer and their roles have been confirmed in animal models that mimic human gastric neoplasia. More genetic factors have also been uncovered and, with advancing technology, there is every prospect of defining a full genetic risk profile in the next decade. This will aid in targeting the testing and treatment of Helicobacter pylori, which offers a true opportunity to prevent and defeat this global killer.

AB - Helicobacter pylori infects half the world's population and is responsible for a considerable global health burden, including peptic ulcer disease and gastric cancer. The infection causes a chronic gastritis, the severity and distribution of which determine the clinical outcome. Bacterial, environmental and host genetic factors combine to define the degree of gastric damage. Most patients have a limited mild pan-gastritis with no significant clinical consequences. Antral-predominant gastritis is associated with high gastric acid output and an increased risk of duodenal ulcers. Corpus-predominant gastritis is associated with a reduction in gastric acid, multifocal gastric atrophy and an increased risk of gastric cancer. Host genetic factors are particularly important in defining the severity and extent of Helicobacter-induced gastritis. The most relevant and consistent genetic factors uncovered thus far are in the interleukin-1 and tumor necrosis factor-A gene clusters. These cytokines appear to play a key role in the pathophysiology of gastric cancer and their roles have been confirmed in animal models that mimic human gastric neoplasia. More genetic factors have also been uncovered and, with advancing technology, there is every prospect of defining a full genetic risk profile in the next decade. This will aid in targeting the testing and treatment of Helicobacter pylori, which offers a true opportunity to prevent and defeat this global killer.

KW - gastritis

KW - helicobacter infections

KW - helicobacter pylori

KW - humans

KW - interleukin-1

KW - multigene family

KW - peptic ulcer

KW - polymorphism, single nucleotide

KW - tumor necrosis factor-alpha

KW - virulence factors

U2 - 10.1111/j.1751-2980.2009.00380.x

DO - 10.1111/j.1751-2980.2009.00380.x

M3 - Article

VL - 10

SP - 157

EP - 164

JO - Journal of Digestive Diseases

JF - Journal of Digestive Diseases

SN - 1751-2972

IS - 3

ER -